Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.2c02120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Isha Singh und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California 94143, United States. Hauptthemen laut MEDLINE: Methyltransferases, COVID-19. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
An under-explored target for SARS-CoV-2 is the S-adenosyl methionine (SAM)-dependent methyltransferase Nsp14, which methylates the N7-guanosine of viral RNA at the 5'-end, allowing the virus to evade host immune response. We sought new Nsp14 inhibitors with three large library docking strategies. First, up to 1.1 billion lead-like molecules were docked against the enzyme's SAM site, leading to three inhibitors with IC50 values from 6 to 50 μM. Second, docking a library of 16 million fragments revealed 9 new inhibitors with IC50 values from 12 to 341 μM. Third, docking a library of 25 million electrophiles to covalently modify Cys387 revealed 7 inhibitors with IC50 values from 3.5 to 39 μM. Overall, 32 inhibitors encompassing 11 chemotypes had IC50 values < 50 μM and 5 inhibitors in 4 chemotypes had IC50 values < 10 μM. These molecules are among the first non-SAM-like inhibitors of Nsp14, providing starting points for future optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California 94143, United States.
- Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
- Graduate Program in Biophysics, University of California San Francisco, San Francisco, California 94143, United States.
- Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
- Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.
- Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California 94158, United States.
ORCID-Profile: Elissa A Fink, Alice Li, Francisco J Zapatero-Belinchón, Xiaobo Wan, Yurii S Moroz, H Ümit Kaniskan, Jian Jin, Danica Galonić Fujimori, Masoud Vedadi, Brian K Shoichet
Förderung
- NIGMS NIH HHS
- NIH HHS
- NIAID NIH HHS
- Defense Advanced Research Projects Agency
- National Institute of Allergy and Infectious Diseases
- National Institute of General Medical Sciences
- Structural Genomics Consortium
- James B. Pendleton Charitable Trust
Zitieren
APA
Singh, I., Li, F., Fink, E. A., Chau, I., Li, A., Rodriguez-Hernández, A., Glenn, I., Zapatero-Belinchón, F. J., Rodriguez, M. L., Devkota, K., Deng, Z., White, K., Wan, X., Tolmachova, N. A., Moroz, Y. S., Kaniskan, H. Ü., Ott, M., García-Sastre, A., Jin, J., …, & Shoichet, B. K. (2023). Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c02120
Vancouver
Singh I, Li F, Fink EA, Chau I, Li A, Rodriguez-Hernández A, et al. Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c02120
BibTeX
@article{Singh2023,
author = {Singh, Isha and Li, Fengling and Fink, Elissa A and Chau, Irene and Li, Alice and Rodriguez-Hernández, Annía and Glenn, Isabella and Zapatero-Belinchón, Francisco J and Rodriguez, M Luis and Devkota, Kanchan and Deng, Zhijie and White, Kris and Wan, Xiaobo and Tolmachova, Nataliya A and Moroz, Yurii S and Kaniskan, H Ümit and Ott, Melanie and García-Sastre, Adolfo and Jin, Jian and Fujimori, Danica Galonić and Irwin, John J and Vedadi, Masoud and Shoichet, Brian K},
title = {Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.2c02120}
}
EUVIMED